Aditi Deshpande

Dr. Aditi Deshpande has a profound understanding of biochemistry and structural biology, which she brings to her role as a part-time Teaching Professor in the Professional MS in Biotechnology (PSM) program at Northeastern University. With a PhD in Biochemistry from Brandeis University, Dr. Deshpande has dedicated over a decade to advancing early-stage biologic drug development programs within the biotech industry. Her expertise is further enriched by her current position as Director of Research and Early Development at ClearB Therapeutics and Orthogonal Neuroscience. Throughout her career, Dr. Deshpande has been instrumental in pioneering innovative approaches to drug development, leveraging her deep knowledge of structural biology to address complex challenges in the field. Her work has not only contributed to the advancement of therapeutic solutions but has also positioned her as a leader in the biotech community. In the classroom, Dr. Deshpande is known for her dynamic teaching philosophy, which emphasizes the importance of building meaningful relationships with students. She is committed to making a difference in their academic and professional journeys by delivering content that goes beyond traditional methods. Her approach fosters an engaging learning environment where students are encouraged to think critically and apply their knowledge in practical settings. Dr. Deshpande's dedication to education and research is reflected in her ability to bridge the gap between academia and industry. Her students benefit from her real-world insights and experience, gaining a comprehensive understanding of the biotechnology landscape. As a mentor, she inspires future leaders in the field, equipping them with the skills and knowledge necessary to excel in their careers. Outside of her professional commitments, Dr. Deshpande is passionate about fostering innovation and collaboration within the scientific community. She actively participates in conferences and workshops, sharing her expertise and learning from peers to stay at the forefront of advancements in biotechnology. Her contributions continue to shape the future of drug development and education, making her a valued member of both the academic and scientific communities.